Access to Chagas disease treatment in the United States after the regulatory approval of benznidazole.

• Auteurs principaux: Kota Yoshioka (Auteur), Jennifer Manne-Goehler (Auteur), James H Maguire (Auteur), Michael R Reich (Auteur)
• Format: Livre
• Publié: Public Library of Science (PLoS), 2020-06-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Approximately 300,000 persons in the United States (US) are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease, but less than 1% are estimated to have received antiparasitic treatment. Benznidazole was approved by the US Food and Drug Administration (FDA) for treatment of T. c...